Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy.
Phase of Trial: Phase III
Latest Information Update: 19 Jan 2018
At a glance
- Drugs Carbamazepine (Primary)
- Indications Epilepsy
- Focus Adverse reactions
- Sponsors Lundbeck Inc
- 01 Jan 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jan 2012 Planned end date changed from 1 Jun 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 20 Sep 2011 Planned end date changed from 1 Sep 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.